Carlos Alban, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 1,918 shares at $69.75 ($134K) on 2012-09-20, disclosed to the SEC on 2012-09-21.
Scheduled sale ($134k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABBV | SELL | 2018-03-02 | $19.1M | — | Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |